Global Controlled Substance Market
Pharmaceuticals

Which Emerging Trends Are Driving The Controlled Substance Market Toward $133.97 Billion By 2029?

Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What Is The Predicted Market Size Of The Controlled Substance Industry By 2029?

The market size for controlled substances has witnessed robust growth in the past few years. It is projected to expand from $94.86 billion in 2024 to reach $100.19 billion by 2025, registering a compound annual growth rate (CAGR) of 5.6%. The historic growth rate can be credited to various factors including improvements in medical science, regulatory guidelines, an increase in chronic disease incidence, the growth of the pharmaceutical industry, global trade, and collaboration.

The market size for controlled substances is projected to experience substantial expansion in the upcoming years, reaching $133.97 billion in 2029 at a Compound Annual Growth Rate (CAGR) of 7.5%. This predicted growth throughout the forecast period can be credited to aspects like precision healthcare, telehealth facilities and remote patient care, substitutes for opioids, continuous updates to regulations and an intensifying focus on mental health. Key trends expected during the forecast period include shifts in regulations and adherence, an increased emphasis on the safety of drugs and prevention of abuse, progress in drug delivery technology, proliferation of biosimilars and generics, and the incorporation of digital health solutions.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9898&type=smp

Which Market Dynamics Are Playing A Critical Role In The Growth Of The Controlled Substance Market?

The controlled substance market is expected to expand due to the rising demand for prescription drugs. Prescription drugs are formulated to manage, treat, cure or prevent diseases and are typically classified as controlled substances. These drugs are beneficial to the controlled substance market as they improve patient results and reduce unnecessary expenditure. In September 2024, a report from the Centers for Medicare and Medicaid Services (CMS), a federal agency based in the US, disclosed that in 2022, expenditures on prescription drugs increased by 8.4% to $405.9 billion, a growth rate higher than the 6.8% in 2021. Thus, the escalating demand for prescribed medicines is propelling the expansion of the controlled substance market.

What Are The Main Segment Classifications In The Controlled Substance Market?

The controlled substance market covered in this report is segmented –

1) By Drug: Opioids, Stimulant, Depressants, Cannabinoids

2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

3) By Application: Pain Management, Sleep Disorders, Depression And Anxiety, Seizure, Attention Deficit Hyperactivity Disorder (ADHD), Other Applications

Subsegments:

1) By Opioids: Natural Opioids, Semi-Synthetic Opioids, Synthetic Opioids

2) By Stimulants: Amphetamines, Methylphenidate, Cocaine

3) By Depressants: Benzodiazepines, Barbiturates, Sleep Medications

4) By Cannabinoids: THC (Tetrahydrocannabinol), CBD (Cannabidiol), Synthetic Cannabinoids

How Are Industry Trends Steering The Expansion Of The Controlled Substance Market?

In the controlled substance market, product innovations are becoming an increasingly important trend. Major players in this market are introducing new drugs and products to maintain their market standing. For instance, UK-based CareFlow Medicines Management Ltd. (CMM), teamed up with Australian healthcare software provider, Modeus, to launch the innovative Controlled Drug Manager (CD Manager) in January 2022. This groundbreaking platform is designed to safely track and manage controlled drugs, including prescription medications owned by patients. The CD Manager, facilitated by Modeus, is designed to seamlessly integrate with both the CMM medication management platform and other external systems. This platform is intended for use by pharmacists and clinical staff in hospitals’ pharmacies, wards, and operating theaters where regulated medicines are stored. Built-in reporting features in CD Manager aid Controlled Drug Accountable Officers in monitoring the journey of controlled substances within an organization. They can also quickly respond to automated alerts about inconsistencies or potential misuse.

Who Are The Major Stakeholders Operating In The Controlled Substance Market?

Major companies operating in the controlled substance market include Merck & Co. Inc., Johnson and Johnson Services Inc., Orbis Biosciences Inc., GW Pharmaceuticals plc, Corium Inc., Aradigm Corporation, Alkermes plc, Sun Pharmaceutical Ltd., F. Hoffmann-La Roche Ltd., AbbVie Inc., Ampac Fine Chemicals, Siegfried Holding AG, Pfizer Inc., Novartis AG, GlaxoSmithKline plc, Sanofi S.A., Bristol-Myers Squibb, Eli Lilly and Company, AstraZeneca, Teva Pharmaceutical Industries, Viatris Inc., Boehringer Ingelheim, Gilead Sciences, Amgen, Regeneron Pharmaceuticals, Abbott Laboratories, Mallinckrodt Pharmaceuticals, Endo International, Catalent, Cambrex Corporation, Lonza Group, Indivior plc, Ipsen SA

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/controlled-substance-global-market-report

What Are The Emerging Regional Trends Driving The Controlled Substance Market?

North America was the largest region in the controlled substance market in 2024. Asia-Pacific is expected to be the fastest-growing region in the controlled substance market report during the forecast period. The regions covered in the controlled substance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=9898&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model